AMR Action Fund said this morning that the first two beneficiaries are Adaptive Phage Therapeutics (APT ... infections through a susceptibility assay, and the approach is being tested clinically ...
University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...
University of Minnesota, Twin Cities, Minneapolis, Minnesota 55409, United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback